• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Single-cell studies of IFN-β promoter activation by wildtype and NS1-defective influenza A viruses

tetano

Editor, Senior Moderator
J Gen Virol. 2016 Dec 15. doi: 10.1099/jgv.0.000687. [Epub ahead of print]
[h=1]Single-cell studies of IFN-β promoter activation by wildtype and NS1-defective influenza A viruses.[/h] Killip MJ[SUP]1[/SUP], Jackson D[SUP]2[/SUP], P?rez-Cidoncha M[SUP]3[/SUP], Fodor E[SUP]4[/SUP], Randall RE[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Deletion or truncation of NS1, the principal interferon (IFN) antagonist of influenza viruses, leads to increased IFN induction during influenza virus infection. We have studied activation of the IFN induction cascade by both wildtype and NS1-defective viruses at the single-cell level using a cell line expressing GFP under the control of the IFN-β promoter and by examining MxA expression. The IFN-β promoter was not activated in all infected cells, even during NS1-defective virus infections. Loss of NS1 expression is therefore by itself insufficient to induce IFN in an infected cell, and factors besides NS1 expression status must dictate whether the IFN response is activated. The IFN response was efficiently stimulated in these cells following infection with other viruses; the differential IFN response we observe with influenza viruses is therefore not cell-specific, but is likely due to differences in the nature of the infecting virus particles and their subsequent replication.


PMID: 27983470 DOI: 10.1099/jgv.0.000687
[PubMed - as supplied by publisher]
 
Back
Top Bottom